Hallucinations after a therapeutic dose of benzodiazepine hypnotics with co‐administration of erythromycin

  title={Hallucinations after a therapeutic dose of benzodiazepine hypnotics with co‐administration of erythromycin},
  author={Noboru Tokinaga and Tsuyoshi Kondo and Sunao Kaneko and Koichi Otani and Kazuo Mihara and Shigeru Morita},
  journal={Psychiatry and Clinical Neurosciences},
Abstract A case of repetitive hallucinations during treatment with a therapeutic dosage of triazolam (0.25 mg/day) and nitrazepam (5 mg/day) is presented. The patient suffered from acute pneumonia and chronic renal failure. Such non‐psychotic symptoms as anxiety, tremor and depressed feeling were observed initially. However, after co‐administration of erythromycin (600 mg/day), visual hallucinations and abnormal bodily sensations developed repeatedly after each administration of triazolam or… 

Visual Hallucinations Associated with Zonisamide

Three patients who experienced complex visual hallucinations and altered mental status after zonisamide treatment was begun or its dosage increased, and their electroencephalogram (EEG) findings were abnormal.

Hallucinations and tremors due to oral therapeutic doses of erythromycin and methylprednisolone

The patient exhibited tremors of head and face, especially of mouth and tongue, and a postural tremor of upper and lower limbs, which increased during movement and altered stability during standing and walking, and the clinical situation could be due to the assumption of erythromycin and steroid therapy.

Hallucinations and delirium in the dental office following triazolam administration.

It is concluded that the proper selection of oral sedation candidates, coupled with recognition and management of adverse events, is essential and complete medical history evaluation before administering oral sedatives is essential.

Erythromycin-induced psychotic decompensation in a patient affected by paranoid schizophrenic psychosis. -

Psychotic decompensation ceased within 48 hours upon discontinuation of erythromycin, and caution is required when using macrolide antibiotics in patients with a psychiatric or neurological disease and after an injury or infection of the brain.

Erythromycin-Induced Psychotic Decompensation in a Patient Affected by Paranoid Schizophrenic Psychosis

Cautions are required when using macrolide antibiotics in patients with a psychiatric or neurological disease and after an injury or infection of the brain, hence caution is required.

Before you blame the morphine: Visual hallucinations in palliative care

While global disturbances such as delirium usually become apparent, those experiencing visual hallucinations are often reluctant to report that they are “seeing things”, for fear of being thought “mad”.

Hypnotics and sedatives

Psychotherapeutic Agents in End‐Stage Renal Disease

A number of agents, such as tricyclic antidepressants, were associated with adverse effects that would be imperative to avoid in patients with ESRD, and should be started at low doses and titrated carefully, while monitoring the efficacy and safety of each agent.

Pharmacokinetic and Pharmacodynamic Consequences of Metabolism‐Based Drug Interactions with Alprazolam, Midazolam, and Triazolam

Ketoconazole and itraconazole were found to be the most potent metabolic inhibitors that prolonged the duration of or intensified the magnitude of the dynamic response produced by the three benzodiazepines.

Clinical Manual of Drug Interaction Principles for Medical Practice

This clinical manual discusses drug interactions by Medical Specialty Gynecology, Internal medicine, Infectious diseases, Neurology Oncology, and Transplant surgery and rheumatology and the implications of drug--drug interactions.



Benzodiazepine dependence. A review of the evidence.

The withdrawal syndrome is characterised by withdrawal symptoms on stopping treatment; these include perceptual disturbances, epileptic seizures, weight loss, insomnia and autonomic symptoms, and may be associated with altered sensitivity of benzodiazepine receptors.

Can a rapidly-eliminated hypnotic cause daytime anxiety?

The very short life of triazolam, leading to daytime withdrawal symptoms, may account for some of the observations, but enhancement of benzodiazepine inverse agonist activity is also hypothesized.

A pharmacokinetic drug interaction between erythromycin and triazolam.

In accordance with previously reported drug interactions involving macrolide antibiotics, erythromycin appears to significantly inhibit the metabolism of triazolam.

Effects of end stage renal disease and aluminium hydroxide on triazolam pharmacokinetics.

It appears that triazolam can be used at normal doses in patients with renal dysfunction, without regard to interaction with aluminum hydroxide gel, or to alterations in elimination.

Alprazolam withdrawal symptoms

Oxidation of midazolam and triazolam by human liver cytochrome P450IIIA4.

The data provide evidence that the marked interindividual variation in the response to these widely used benzodiazepine drugs is due to variable hepatic metabolism, and predominantly mediated by cytochrome P450IIIA4.

Het Halcion - syndroom - een iatrogene epdi - emie in Nederland

  • T . Alc . Drugs
  • 1982